Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 3

1(14.3%)

7Total

N/A(6)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06035991Not ApplicableActive Not Recruiting

First Clinical Evaluation of Heart Transplantation With Grafts Preserved Using an Ex-vivo Extended Perfusion System

Role: collaborator

NCT04951999Not ApplicableCompleted

AssocIation of PULSatility and Occurrence of Complications Related to Mechanically Assisted Circulatory Support

Role: collaborator

NCT05479721Active Not Recruiting

LITMUS Imaging Study

Role: collaborator

NCT03837925Phase 3Completed

Pharmaco-metabolomic Effects of Statins: METASTATINE

Role: collaborator

NCT03732690Not ApplicableCompleted

The Interaction Between Protein Intake, Gut Microbiota and Type 2 Diabetes in Subjects With Different Ethnic Backgrounds

Role: collaborator

NCT03090867Not ApplicableUnknown

Participation of Relative or Surrogate in the Patient's Care in Reanimation

Role: collaborator

NCT03267901Not ApplicableCompleted

Effects of Daily Walnut Intake Among the Subjects With Metabolic Syndrome

Role: lead

NCT03014531Not ApplicableCompleted

Effects of Daily Almond Intake as a Preload Before Meals Versus as a Snack Among Korean Adults

Role: lead

All 8 trials loaded